Sunho Biologics, Inc. (HKG:2898)
Hong Kong
· Delayed Price · Currency is HKD
6.40
0.00 (0.00%)
At close: Mar 10, 2026
Sunho Biologics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -82.09 | -79.97 | -132.7 | -51.99 | -70.63 |
| Depreciation & Amortization | 9.66 | 9.43 | 8.64 | 8.81 | 6.07 |
| Loss (Gain) From Sale of Investments | - | - | - | -0.06 | -0.15 |
| Stock-Based Compensation | 28.35 | 28.35 | 30.08 | 2.04 | 8.3 |
| Other Operating Activities | 41.19 | -44.79 | 46.86 | 5.03 | 4.17 |
| Change in Inventory | -0.16 | -0.16 | 0.06 | 0.29 | 0.49 |
| Change in Accounts Payable | -14.46 | -14.46 | 9.33 | -1.45 | 1.3 |
| Change in Other Net Operating Assets | -7.43 | -7.43 | -2.92 | 2.74 | -2.21 |
| Operating Cash Flow | -24.94 | -109.02 | -40.65 | -34.59 | -52.65 |
| Capital Expenditures | -41.05 | -39.37 | -1.03 | -1.44 | -5.52 |
| Sale (Purchase) of Intangibles | -9.89 | -9.89 | - | - | -5 |
| Investment in Securities | -227.84 | -294.17 | -85.6 | 0.06 | 0.15 |
| Other Investing Activities | -35.02 | -1.6 | 2.74 | 0.02 | 0.01 |
| Investing Cash Flow | -314.51 | -345.04 | -83.89 | -1.36 | -10.36 |
| Short-Term Debt Issued | - | 47.28 | 23 | 42.7 | 74.24 |
| Total Debt Issued | 66.1 | 47.28 | 23 | 42.7 | 74.24 |
| Short-Term Debt Repaid | - | -32.51 | -34.52 | -15.14 | -9.26 |
| Long-Term Debt Repaid | - | -2.4 | -0.02 | - | - |
| Total Debt Repaid | -47.33 | -34.91 | -34.54 | -15.14 | -9.26 |
| Net Debt Issued (Repaid) | 18.77 | 12.37 | -11.54 | 27.56 | 64.98 |
| Issuance of Common Stock | - | 419.78 | 270.52 | - | - |
| Other Financing Activities | -2.18 | -25.61 | -3.48 | -0.46 | - |
| Financing Cash Flow | 16.59 | 406.53 | 255.5 | 27.1 | 64.98 |
| Foreign Exchange Rate Adjustments | 0.15 | 1.44 | -7.7 | - | - |
| Net Cash Flow | -322.72 | -46.08 | 123.25 | -8.84 | 1.97 |
| Free Cash Flow | -65.98 | -148.39 | -41.68 | -36.03 | -58.17 |
| Free Cash Flow Margin | -388135.29% | -390505.26% | -237.73% | -1947.30% | -1808.71% |
| Free Cash Flow Per Share | -0.44 | -1.16 | -0.45 | -0.40 | -0.64 |
| Cash Interest Paid | 1.48 | 0.7 | - | - | - |
| Levered Free Cash Flow | -118.56 | -471.93 | 315.72 | -26.49 | - |
| Unlevered Free Cash Flow | -117.83 | -471.35 | 316.15 | -23.32 | - |
| Change in Working Capital | -22.04 | -22.04 | 6.47 | 1.59 | -0.41 |
Source: S&P Capital IQ. Standard template.
Financial Sources.